Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection

Jiaojiao Tang1,2, Nathan W Kong3, Andrew Beaser1

  • 1Center for Arrhythmia Care, Heart and Vascular Institute, The University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, MC 9024, Chicago, IL, 60637, USA.

Insights

Conduction system pacing (CSP) and biventricular pacing (BiVP) show similar mid-term clinical outcomes in heart failure patients with mid-range ejection fraction. Both pacing methods effectively improve left ventricular ejection fraction (LVEF) with comparable safety profiles.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Limited comparative data exists for conduction system pacing (CSP) versus biventricular pacing (BiVP) in heart failure (HF) patients with mid-range left ventricular ejection fraction (LVEF).
  • Understanding the efficacy and safety of alternative pacing strategies is crucial for optimizing HF treatment.

Purpose of the Study:

  • To compare the clinical outcomes of CSP and BiVP in patients diagnosed with HF and mid-range LVEF.
  • To evaluate differences in lead performance, LVEF changes, HF hospitalizations, and composite clinical outcomes.

Main Methods:

  • Retrospective analysis of patients with mid-range LVEF (35-50%) who underwent either CSP or BiVP.
  • Comparison of procedural metrics, QRS duration, lead thresholds, battery longevity, LVEF, HF hospitalizations, and a composite clinical outcome.
  • Included His bundle pacing and left bundle branch area pacing within the CSP group.

Main Results:

  • No significant differences in procedural time, fluoroscopy time, or lead thresholds were observed between CSP and BiVP groups.
  • Both pacing strategies led to significant improvements in LVEF during mid-term follow-up.
  • HF hospitalizations and composite clinical outcomes were comparable between the CSP and BiVP groups.

Conclusions:

  • Conduction system pacing (CSP) demonstrates comparable mid-term clinical outcomes and LVEF improvements to biventricular pacing (BiVP) in heart failure patients with moderately reduced ejection fraction.
  • CSP represents a viable alternative pacing strategy in this patient population, offering similar efficacy and safety.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
547
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
324
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
620